Dennis Matheis, Director at DarioHealth Corp. (DRIO), bought 14,430 shares at $6.93 ($100K) on 2026-07-23, disclosed to the SEC on 2026-07-28.
Director Dennis Matheis executed a rare, largest-ever insider purchase of 14,430 shares at $6.93 on July 23, signaling strong conviction in the stock's recovery potential. This move comes as the stock rallies 12% over the last five days, potentially validating the recent shift in business strategy.
DRIO has surged 12% over the past five days and is up nearly 10% over the last 30 days, reclaiming some ground after a 40% year-to-date decline. The stock is currently trading 25.78% above its 52-week low of $5.94, though it remains 57.93% below the 52-week high of $17.74.
Despite recent gains, the stock remains significantly below its 52-week high, and the company reported a revenue miss of -16.37% in Q2 2026, highlighting execution risks in transitioning away from pharmaceutical services.
Something here stands out, but not much.
| Filing → |
| LUCD | BUY | 2025-05-23 | $873K | — | Filing → |